Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bo-112 (4 trials)
nivolumab (opdivo) (2 trials)
pembrolizumab (keytruda) (3 trials)
poly-iclc (1 trial)
Colorectal Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (4 total)